Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
vm-001 (1 trial)
vt-ebv-n (1 trial)
Lymphoma (Phase 2)
Lymphoma, Extranodal NK-T-Cell (Phase 2)
Lymphoma, T-Cell (Phase 2)
Trials (2 total)
Trial APIs (2 total)